Investor Stock List
Ranked #853 of 8,699 institutional investors

Orbimed Advisors LLC

New York, NY

$4.74B
US stock portfolio at live prices · today +$18.6M (+0.39%)
Market closed. Prices as of Nov 20, 6:41 AM ET
Value at quarter end (Q3 2026)
$5.26B
Change from Q2 2026
+$164.5M (+3.23%)
Positions
105 · 27 new, 27 sold out
Filed
Nov 16, 2026

Not counted in the ranking: call options on $44.4M of stock, put options on $1.2M, $10.5M of convertible notes and other principal-amount securities. $308M of holdings we could not match to a US listing are included at their reported quarter-end value.

Holdings

Q3 2026 13F, live prices
EWTX 13.5%LLY 7.35%ADRX 7.23%ELVN 6.63%BRVE 4.95%
StockSharesValue, live% of portfoliovs Q2 2026
EWTX Edgewise Therapeutics, Inc.15,518,492$639M13.5%Unchanged
LLY Eli Lilly and Company257,900$348M7.35%Unchanged
ADRX ADARx Pharmaceuticals, Inc.24,205,789$343M7.23%New
ELVN Enliven Therapeutics, Inc.6,776,632$315M6.63%Unchanged
BRVE Braveheart Bio, Inc.12,175,159$235M4.95%New
MBX MBX Biosciences, Inc.3,074,853$164M3.46%Reduced −10%
MRK Merck & Co., Inc.946,100$126M2.65%Added +43%
EW Edwards Lifesciences Corporation834,900$86.7M1.83%Unchanged
GH Guardant Health, Inc.584,100$85.0M1.79%Unchanged
ARQT Arcutis Biotherapeutics, Inc.3,122,100$84.8M1.79%Added +53%
TMO Thermo Fisher Scientific Inc.120,400$82.9M1.75%Added +33%
ABBV AbbVie Inc.259,600$73.6M1.55%New
UNH UnitedHealth Group Incorporated219,000$72.4M1.53%Added +36%
CRVS Corvus Pharmaceuticals, Inc.7,165,006$71.7M1.51%Unchanged
ARGX argenx SE75,180$70.8M1.49%Reduced −19%
CDNA CareDx, Inc.934,800$67.2M1.42%New
TNGX Tango Therapeutics, Inc.2,777,621$63.1M1.33%New
PRAX Praxis Precision Medicines, Inc.200,400$62.3M1.31%Reduced −13%
ETRA Electra Therapeutics, Inc.6,885,170$61.6M1.30%New
ABT Abbott Laboratories579,000$60.1M1.27%New
TVTX Travere Therapeutics, Inc.1,200,425$58.0M1.22%Added +374%
NTRA Natera, Inc.199,700$57.9M1.22%Reduced −24%
COGT Cogent Biosciences, Inc.2,003,700$55.6M1.17%Added +19%
ODTX Odyssey Therapeutics, Inc.3,001,198$55.0M1.16%Unchanged
HUM Humana Inc.127,800$48.6M1.02%Reduced −22%
RYTM Rhythm Pharmaceuticals, Inc.408,000$47.7M1.00%Added +26%
PRLD Prelude Therapeutics Incorporated13,724,571$44.7M0.94%Unchanged
CAI Caris Life Sciences, Inc.2,192,911$40.7M0.86%Reduced −22%
ISRG Intuitive Surgical, Inc.96,800$39.4M0.83%Reduced −39%
BLSM BlossomHill Therapeutics, Inc.2,714,279$39.1M0.82%New
QTTB Q32 Bio Inc.4,127,987$35.0M0.74%Unchanged
AVBP ArriVent BioPharma, Inc.3,027,328$34.1M0.72%Unchanged
PVLA Palvella Therapeutics, Inc.229,860$33.5M0.71%Reduced −21%
WST West Pharmaceutical Services, Inc.80,180$31.8M0.67%Added +14%
KRYS Krystal Biotech, Inc.97,700$30.9M0.65%Added +17%
STTK Shattuck Labs, Inc.6,306,127$28.7M0.61%Unchanged
SPRY ARS Pharmaceuticals, Inc.8,288,510$27.8M0.59%Unchanged
AURA Aura Biosciences, Inc.3,333,333$23.3M0.49%Unchanged
AXSM Axsome Therapeutics, Inc.170,878$23.2M0.49%Added +45%
GPCR Structure Therapeutics Inc.1,331,000$22.8M0.48%Reduced −40%
DXCM DexCom, Inc.278,000$22.3M0.47%New
LTGO Latigo Biotherapeutics, Inc.1,675,316$22.2M0.47%New
SVRA Savara Inc.3,959,900$20.6M0.44%Unchanged
MLYS Mineralys Therapeutics, Inc.1,454,572$20.6M0.43%Reduced −31%
BIIB Biogen Inc.79,400$19.6M0.41%Added +29%
WAT Waters Corporation40,300$18.4M0.39%Unchanged
SCTX Scribe Therapeutics Inc.1,348,825$17.8M0.38%New
CELC Celcuity Inc.314,500$17.7M0.37%New
APMD Apnimed, Inc.925,000$16.0M0.34%New
ABVX ABIVAX Société Anonyme185,022$14.9M0.31%Reduced −66%
CVS CVS Health Corporation182,600$14.6M0.31%New
CLDX Celldex Therapeutics, Inc.505,000$14.1M0.30%New
PYXS Pyxis Oncology, Inc.8,361,917$14.0M0.30%New
QUIT Achieve Life Sciences, Inc.2,344,200$13.8M0.29%New
VRTX Vertex Pharmaceuticals Incorporated26,200$13.6M0.29%New
TRVI Trevi Therapeutics, Inc.965,300$13.2M0.28%Reduced −33%
DFTX Definium Therapeutics, Inc.443,900$13.1M0.28%Added +21%
NKTR Nektar Therapeutics384,520$12.5M0.26%Reduced −17%
VOGX Vogenx, Inc.968,621$12.4M0.26%New
WHWK Whitehawk Therapeutics, Inc.3,853,472$12.0M0.25%Reduced −2%
ORIC ORIC Pharmaceuticals, Inc.1,555,900$12.0M0.25%Reduced −23%
ERAS Erasca, Inc.806,000$11.5M0.24%Added +63%
UPB Upstream Bio, Inc.5,693,589$11.4M0.24%Unchanged
RVMD Revolution Medicines, Inc.70,500$11.2M0.24%Unchanged
BCRX BioCryst Pharmaceuticals, Inc.1,506,000$11.0M0.23%Reduced −19%
CMPX Compass Therapeutics, Inc.15,219,994$10.3M0.22%Unchanged
SPRB Spruce Biosciences, Inc.242,800$9.8M0.21%Added +21%
LXEO Lexeo Therapeutics, Inc.3,203,050$9.4M0.20%Reduced −19%
KROS Keros Therapeutics, Inc.759,155$8.6M0.18%Unchanged
NPCE NeuroPace, Inc.1,055,125$8.6M0.18%Reduced −30%
ARWR Arrowhead Pharmaceuticals, Inc.194,300$8.5M0.18%New
TSHA Taysha Gene Therapies, Inc.2,000,000$7.5M0.16%Unchanged
SION Sionna Therapeutics, Inc.2,469,959$7.3M0.15%Reduced −3%
STRO Sutro Biopharma, Inc.743,944$6.5M0.14%Unchanged
JANX Janux Therapeutics, Inc.524,700$5.4M0.11%Unchanged
RLMD Relmada Therapeutics, Inc.1,670,079$5.2M0.11%Reduced −54%
SYRE Spyre Therapeutics, Inc.47,326$4.6M<0.1%Reduced −75%
XLO Xilio Therapeutics, Inc.592,300$4.4M<0.1%Unchanged
DHR Danaher Corporation18,600$4.2M<0.1%New
CRBP Corbus Pharmaceuticals Holdings, Inc.1,665,656$4.1M<0.1%Reduced −4%
YARW Yarrow Bioscience, Inc.266,306$3.8M<0.1%New
IMA ImageneBio, Inc.909,269$3.6M<0.1%Unchanged
DNTH Dianthus Therapeutics, Inc.42,300$3.6M<0.1%Reduced −63%
IMUX Immunic, Inc.475,804$3.5M<0.1%New
TECX Tectonic Therapeutic, Inc.166,102$3.5M<0.1%Reduced −27%
BIOA BioAge Labs, Inc.711,811$3.4M<0.1%Reduced −5%
BMRN BioMarin Pharmaceutical Inc.54,300$3.3M<0.1%New
AORT Artivion, Inc.175,000$3.2M<0.1%Unchanged
MDGL Madrigal Pharmaceuticals, Inc.8,000$3.2M<0.1%New
BRKR Bruker Corporation48,400$3.0M<0.1%New
PTCT PTC Therapeutics, Inc.49,100$2.9M<0.1%Unchanged
ALXO ALX Oncology Holdings Inc.2,742,968$2.8M<0.1%Reduced −4%
TARS Tarsus Pharmaceuticals, Inc.34,600$2.7M<0.1%Reduced −3%
ALMS Alumis Inc.548,163$2.4M<0.1%Unchanged
ACET Adicet Bio, Inc.844,787$2.1M<0.1%Unchanged
BLTE Belite Bio, Inc13,300$2.0M<0.1%Unchanged
NSPR InspireMD, Inc.3,133,405$1.9M<0.1%Unchanged
ZNTL Zentalis Pharmaceuticals, Inc.1,315,355$1.8M<0.1%Reduced −5%
DRUG Bright Minds Biosciences Inc.81,000$1.7M<0.1%Reduced −13%
UNCY Unicycive Therapeutics, Inc.387,000$1.4M<0.1%New
OCUL Ocular Therapeutix, Inc.220,000$1.3M<0.1%Unchanged
EPRX Eupraxia Pharmaceuticals Inc.194,720$1.2M<0.1%Reduced −28%
EVMN Evommune Inc161,000$1.2M<0.1%Unchanged
TRAW Traws Pharma, Inc.1,203,260$277K<0.1%Unchanged
EYPT EyePoint, Inc.739,691$195K<0.1%Reduced −31%

Sold out in Q3 2026

StockShares held at Q2 2026Worth today
CGON CG Oncology, Inc.972,800$79.7M
BSX Boston Scientific Corporation1,483,200$63.8M
BMY Bristol-Myers Squibb Company925,000$54.0M
DYN Dyne Therapeutics, Inc.3,235,684$51.9M
SYK Stryker Corporation159,100$49.8M
ELV Elevance Health, Inc.114,700$44.8M
XENE Xenon Pharmaceuticals Inc.892,471$33.5M
IRON Disc Medicine, Inc.357,535$27.2M
SNDX Syndax Pharmaceuticals, Inc.1,542,000$14.1M
LFST LifeStance Health Group, Inc.947,400$12.6M
MNPR Monopar Therapeutics Inc.157,423$11.1M
VERA Vera Therapeutics, Inc.369,596$9.9M
ANRO Alto Neuroscience Inc257,852$6.8M
TARA Protara Therapeutics, Inc.2,220,000$5.3M
PTGX Protagonist Therapeutics, Inc.42,100$5.2M
AMLX Amylyx Pharmaceuticals, Inc.183,400$4.8M
ALNY Alnylam Pharmaceuticals, Inc.17,000$2.5M
ACAD Acadia Pharmaceuticals Inc.137,000$2.4M
PALI Palisade Bio, Inc.2,333,000$2.2M
TYRA Tyra Biosciences, Inc.102,000$2.0M
RAPP Rapport Therapeutics, Inc.76,616$1.8M
OVID Ovid Therapeutics Inc.747,000$1.7M
BCAX Bicara Therapeutics Inc.191,100$1.7M
ACRS Aclaris Therapeutics, Inc.421,500$1.5M
CYTK Cytokinetics, Incorporated25,800$1.3M
AGMB AgomAb Therapeutics NV192,740$1.1M
NMRA Neumora Therapeutics, Inc.2,139,882$743K